Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Tuesday 13 January 2015 9:01 pm

Integrated Diagnostics Holdings IPO: Egypt’s IDH sets February target for London float

By: Express KCS

Add as a preferred source on Google

Medical laboratory services firm Integrated Diagnostics Holdings (IDH) is aiming to list on the London Stock Exchange in February.

The Egypt-based company, which is registered in Jersey and also operates in Jordan and Sudan, was formed out of the 2012 merger of Al Mokhtabar and Al Borg Laboratories.
 
Its IPO will incorporate a sale of existing shares by shareholders Integrated Diagnostics Group Limited, controlled by private equity investor Abraaj Group, and Hena Holdings, controlled by the founders of IDH. 
 
The selling shareholders are seeking to realise part of their investment in the company in a sale of up to 45 per cent of its share capital. 
 
Commenting on the proposed float, Dr Hend El Sherbini, IDH’s chief executive, said: “Over the years, we have built a company that is now widely recognised and respected in Egypt and beyond.”
 
She added that IDH’s “strong market position” enables it to provide crucial diagnostics services in markets that are still largely under-served and unpenetrated.
 
IDH reported profit 157.2m Eygptian pounds (£14.5m) in the first nine months of last year, and operated 283 labs as of 30 September 2014.
 
El Sherbini continued: “As we continue to build on our success to date, reflecting years of profitable growth, high margins and operational excellence, we believe IDH represents a highly attractive future growth story.  This initial public offering is a pivotal next step for us that will allow us to further accelerate our market penetration and expand our service offerings.”
 

BEHIND THE DEAL: DEUTSCHE BANK | CHRISTOPHER LAING

 
1 Laing, who is leading the deal, is a managing director at Deutsche Bank with responsibility for emerging markets, and has focused on the Middle East and Africa since 2008.
 
2 He was lead adviser on the IPOs of both Al Noor Hospitals and NMC Health, and previously worked on Dubai Port World’s $4.2bn IPO in 2007 and Kingdom Hotel Investments’ $397m float.
 
3 Laing is a rugby fan with ambitions to see England lift the World Cup this year. However, most of his free time is spent with his family, which includes eight-year-old identical twin boys.  
 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • IPOs

Trending Articles

  • Brewdog chief executive quits after only one year

  • Housebuilding giants hit with £4.5bn lawsuit for allegedly overcharging buyers

  • As it happened: Stocks jump on defence and metals boost; Oil on track to shed a fifth on US-Iran peace hopes

  • UK ‘no longer a serious place’ says Hedge fund boss after losing £200m tax battle

  • Canary Wharf’s reinvention is a triumph

More from City PM

  • Starling names HSBC veteran as chair in boardroom shake-up on road to IPO

    Fintech
    Starling Bank integrates Apple Pay 2022, showcasing digital banking innovation and seamless mobile payment solutions
  • Boots eyes £7.5bn sale in blow to hopes of London IPO

    Retail
    Boots remains one of the group’s best performing business lines, with a London float suggested as recently as last year. (Photo by Oli Scarff/Getty Images)
  • Boots moves closer to London float but billionaire Westons circle

    Retail
    A pair of stylish and durable boots showcased on a wooden floor, highlighting their craftsmanship and premium leather qual...
  • Tottenham Hotspur: Daniel Levy sells majority of shares in Spurs owner ENIC

    Sport Business
    Due to the lack of specific context or details about the image or the articles content, I cannot generate a precise alt te...
  • Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

    Business Wire
  • Promega Receives SBTi Validation for Near-Term Science-Based Emissions Reduction Targets

    Business Wire
  • Australian pharma giant Sigma quits Boots takeover talks

    Retail
    Anthony Hemmerdinger will take over the role from Seb James later this year.
  • Eckuity Capital Launches Fund II and Backs Automata Technologies

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy